Occudo Quantitative Strategies LP Acquires Shares of 27,602 Aflac Incorporated (NYSE:AFL)

Occudo Quantitative Strategies LP purchased a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 27,602 shares of the financial services provider's stock, valued at approximately $2,855,000.

Other large investors also recently bought and sold shares of the company. Barclays PLC increased its holdings in shares of Aflac by 10.1% during the 3rd quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider's stock worth $155,529,000 after buying an additional 127,911 shares during the last quarter. Czech National Bank raised its position in Aflac by 5.6% in the fourth quarter. Czech National Bank now owns 108,405 shares of the financial services provider's stock valued at $11,213,000 after purchasing an additional 5,731 shares during the period. Aprio Wealth Management LLC lifted its stake in shares of Aflac by 10.5% in the 4th quarter. Aprio Wealth Management LLC now owns 4,161 shares of the financial services provider's stock valued at $430,000 after purchasing an additional 397 shares during the last quarter. Eagle Bay Advisors LLC purchased a new position in shares of Aflac during the 4th quarter worth $74,000. Finally, Wedmont Private Capital increased its position in shares of Aflac by 25.8% during the 4th quarter. Wedmont Private Capital now owns 8,809 shares of the financial services provider's stock worth $890,000 after purchasing an additional 1,809 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.

Aflac Price Performance

NYSE:AFL traded up $1.18 during mid-day trading on Friday, reaching $106.96. 3,427,209 shares of the company were exchanged, compared to its average volume of 2,114,090. Aflac Incorporated has a 12 month low of $86.46 and a 12 month high of $115.50. The company has a fifty day moving average of $106.99 and a 200 day moving average of $106.51. The stock has a market cap of $57.83 billion, a PE ratio of 11.14, a PEG ratio of 3.24 and a beta of 0.84. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. The company's revenue was down 37.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.66 EPS. On average, research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date of this dividend is Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is currently 36.25%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company lifted their price objective on Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 6th. StockNews.com lowered Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. JPMorgan Chase & Co. upped their price target on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Piper Sandler lifted their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Finally, BMO Capital Markets began coverage on Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $104.21.

Insider Transactions at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director now owns 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This trade represents a 3.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 31,802 shares of company stock worth $3,411,877 in the last three months. Insiders own 0.90% of the company's stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.